Ticker
XGNCompany Name
EXAGEN INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 58.76M | $ -16.98M | -28.9% |
3/31/2025 | $ 40.29M | $ -15.51M | -38.48% |
12/31/2024 | $ 44.69M | $ -15.12M | -33.82% |
9/30/2024 | $ 43.6M | $ -16.93M | -38.82% |
6/30/2024 | $ 49.31M | $ -17.31M | -35.11% |
3/31/2024 | $ 50.81M | $ -19.36M | -38.11% |
12/31/2023 | $ 56.94M | $ -23.69M | -41.6% |
9/30/2023 | $ 60.93M | $ -32.47M | -53.29% |
6/30/2023 | $ 64.18M | $ -35.15M | -54.77% |
3/31/2023 | $ 79.23M | $ -44.8M | -56.55% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for EXAGEN INC is calculated as follows: Net Inc. Cmn. [ $ -16.64M ] / Assets [ $ 79.99M ]
(=) ROA [ -20.8% ]
Minimum
Mar 31, 2023
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.45K |
---|---|
min | -33.42% |
max | 33.98% |
average | 0.09% |
median | 1.53% |
std | 10.64% |